secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2026-06-01T13:02:13+00:00
Accession:  0001213900-26-063185
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma announces 1-for-15 reverse stock split effective June 2, 2026
-------------------------------------------------------------------------

- 1-for-15 reverse split effective 4:01 pm ET on June 2, 2026; post-split trading begins June 3 under same symbol SILO.
- Outstanding shares reduced from ~16.267M to ~1.084M; authorized shares cut proportionately to 6,666,667.
- CUSIP changes to 82711P 300; fractional shares rounded up to the next whole share.
- Equitable adjustments made to equity awards and warrants, including exercise prices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026063185/0001213900-26-063185-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026063185/ea0292702-8k_silo.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-063185

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer